Home
Career Stage
Medical Students Residents Attendings CPT Codes Resources Blog Support

J0517 Injection., benralizumab, 1 milligrams

J Codes (Drugs)

Also known as: benralizumab, Fasenra

Benralizumab injection, 1 milligram, a monoclonal antibody that targets interleukin-5 for treatment of severe eosinophilic asthma.

In Plain Language

severe asthma injection; eosinophil-targeting medication

Clinical Context

Indicated for moderate to severe eosinophilic asthma in patients inadequately controlled on inhaled corticosteroids. Administered subcutaneously every 4 weeks for 3 doses, then every 8 weeks.

RVU Information

CPT J0517 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.

Billing & Documentation

J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.

Specialties

pulmonologyimmunologyallergy

Frequently Asked Questions

What is CPT code J0517?

CPT J0517 (Injection., benralizumab, 1 milligrams) is a J Codes (Drugs) code. Benralizumab injection, 1 milligram, a monoclonal antibody that targets interleukin-5 for treatment of severe eosinophilic asthma.

How is J0517 administered?

CPT J0517 is administered by a healthcare provider, typically via injection or infusion. Indicated for moderate to severe eosinophilic asthma in patients inadequately controlled on inhaled corticosteroids. Administered subcutaneously every 4 weeks for 3 doses, then every 8 weeks. It is used by pulmonology, immunology, allergy.

When is CPT J0517 used?

Indicated for moderate to severe eosinophilic asthma in patients inadequately controlled on inhaled corticosteroids. Administered subcutaneously every 4 weeks for 3 doses, then every 8 weeks.

Track This Code in RVU Edge

Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.

CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.